Radiopharma biotech Cellectar Biosciences is seeking strategic alternatives, opening the door to further opportunities after ...

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...

Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

Portage Biotech Inc.'s (PRTG) shares soared over 27% on Monday, marking their best session in more than three weeks, after ...

Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak ...

Shares of Biohaven ( BHVN 5.24%) are surging on Monday. The company's stock was up about 8% as of midday trading and had ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Nautilus Biotechnology, Inc.’s NAUT share price has dipped by 7.04%, which has investors questioning if this is right time to ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Oncolytics Biotech Inc.’s ONCY share price has dipped by 5.04%, which has investors questioning if this is right time to buy.

The preclinical results were highlighted at the AACR Annual Meeting in Chicago, Illinois, on April 28, 2025, drawing ...